PL338439A1 - Drug delivering systems and method of treating viral and bacterial infections as well as cachexia syndromes - Google Patents

Drug delivering systems and method of treating viral and bacterial infections as well as cachexia syndromes

Info

Publication number
PL338439A1
PL338439A1 PL98338439A PL33843998A PL338439A1 PL 338439 A1 PL338439 A1 PL 338439A1 PL 98338439 A PL98338439 A PL 98338439A PL 33843998 A PL33843998 A PL 33843998A PL 338439 A1 PL338439 A1 PL 338439A1
Authority
PL
Poland
Prior art keywords
well
bacterial infections
treating viral
drug delivering
delivering systems
Prior art date
Application number
PL98338439A
Other versions
PL196256B1 (en
Original Assignee
Cryopreservation Tech Cc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Cryopreservation Tech Cc filed Critical Cryopreservation Tech Cc
Publication of PL338439A1 publication Critical patent/PL338439A1/en
Publication of PL196256B1 publication Critical patent/PL196256B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL338439A 1997-06-13 1998-06-09 Drug delivering systems and method of treating viral and bacterial infections as well as cachexia syndromes PL196256B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en) 1997-06-13 1998-06-09 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (2)

Publication Number Publication Date
PL338439A1 true PL338439A1 (en) 2000-11-06
PL196256B1 PL196256B1 (en) 2007-12-31

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
PL338439A PL196256B1 (en) 1997-06-13 1998-06-09 Drug delivering systems and method of treating viral and bacterial infections as well as cachexia syndromes

Country Status (34)

Country Link
EP (1) EP1011567A1 (en)
JP (1) JP4531141B2 (en)
KR (1) KR20010013709A (en)
CN (1) CN1260703A (en)
AP (1) AP1629A (en)
AR (1) AR012970A1 (en)
AU (1) AU7831598A (en)
BG (1) BG103997A (en)
BR (1) BR9810095A (en)
CA (1) CA2295176A1 (en)
CZ (1) CZ298510B6 (en)
EA (1) EA200000011A1 (en)
EE (1) EE9900562A (en)
ES (1) ES2161187B1 (en)
FI (1) FI19992648L (en)
GB (1) GB2341319B (en)
HU (1) HUP0003034A2 (en)
ID (1) ID23516A (en)
IL (2) IL133396A0 (en)
IS (1) IS5289A (en)
LT (1) LT4714B (en)
LV (1) LV12490B (en)
NO (1) NO996117L (en)
NZ (1) NZ501669A (en)
OA (1) OA11307A (en)
PL (1) PL196256B1 (en)
RO (1) RO121252B1 (en)
SI (1) SI20191A (en)
SK (1) SK172299A3 (en)
TN (1) TNSN98086A1 (en)
TR (1) TR200000540T2 (en)
WO (1) WO1998056325A1 (en)
YU (1) YU66099A (en)
ZA (1) ZA984649B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2290738T3 (en) * 2003-06-30 2008-02-16 Alza Corporation PROCEDURE FOR COVERING SKIN PERFORATION MICROPROJECTIONS.
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
EP0626945B1 (en) * 1992-02-20 1998-04-22 Merrell Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
EA001957B1 (en) * 1995-12-15 2001-10-22 Вироден Фармасьютикал Холдингс (Проприетэри) Лимитед COMPOSITION FOR THE TREATMENT OF AIDS

Also Published As

Publication number Publication date
SK172299A3 (en) 2000-09-12
CA2295176A1 (en) 1998-12-17
AR012970A1 (en) 2000-11-22
NZ501669A (en) 2001-09-28
KR20010013709A (en) 2001-02-26
WO1998056325A1 (en) 1998-12-17
HUP0003034A2 (en) 2000-12-28
EA200000011A1 (en) 2000-08-28
ZA984649B (en) 1999-12-17
LV12490B (en) 2000-12-20
NO996117L (en) 2000-02-11
GB9929189D0 (en) 2000-02-02
IS5289A (en) 1999-12-08
NO996117D0 (en) 1999-12-10
SI20191A (en) 2000-10-31
ES2161187B1 (en) 2003-08-16
GB2341319B (en) 2002-02-27
IL133396A0 (en) 2001-04-30
TNSN98086A1 (en) 2005-03-15
BG103997A (en) 2001-07-31
FI19992648A7 (en) 2000-02-03
LT99148A (en) 2000-07-25
PL196256B1 (en) 2007-12-31
AP1629A (en) 2006-07-11
GB2341319A (en) 2000-03-15
ID23516A (en) 2000-04-27
EP1011567A4 (en) 2000-06-28
JP2002511862A (en) 2002-04-16
CN1260703A (en) 2000-07-19
CZ9904473A3 (en) 2001-03-14
BR9810095A (en) 2001-11-13
OA11307A (en) 2003-10-24
RO121252B1 (en) 2007-02-28
EP1011567A1 (en) 2000-06-28
TR200000540T2 (en) 2000-09-21
ES2161187A1 (en) 2001-11-16
JP4531141B2 (en) 2010-08-25
FI19992648L (en) 2000-02-03
AU7831598A (en) 1998-12-30
AP9901708A0 (en) 1999-12-31
LV12490A (en) 2000-06-20
CZ298510B6 (en) 2007-10-24
EE9900562A (en) 2000-06-15
YU66099A (en) 2002-10-18
IL133396A (en) 2006-10-05
LT4714B (en) 2000-10-25

Similar Documents

Publication Publication Date Title
EP1109580A4 (en) Methods for treating or preventing viral infections and associated diseases
EP1115286A4 (en) Methods for treating or preventing viral infections and associated diseases
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
GB2372682B (en) Broadcast method and system
AU2663097A (en) Compounds and methods for the selective treatment of cancer and bacterial infections
AU4813197A (en) Compositions and methods for treating viral infections
GB0405067D0 (en) Broadcast method and system
SG83218A1 (en) Nitrous oxide purification system and process
IL149655A0 (en) Improved transdermal contraceptive delivery system and process
GB9709360D0 (en) Methods for the treatment of herpes virus infections
IL133208A0 (en) Affiliate dissemination method and system
PL312908A1 (en) Drugs for treating aids and/or hiv infections, containing composition consisting of quinoxalin and protease inhibitors
EP0643074A3 (en) Viral infection and proliferation inhibitors.
IL129387A0 (en) Methods and compositions for delivery and expression of interferon-alpha nucleic acids
EP0921803A4 (en) Methods for preventing and treating pestivirus infection and associated diseases
HUP0203908A3 (en) Osmotic delivery system and method for delivery first of all of medicine
ZA972722B (en) Method for prevention and treatment of viral infectious diseases.
IL126121A0 (en) Vaccines for treatment of lymphoma and leukemia
ZA200107523B (en) Method for improving the stability of stored and/or light-sensitive therapeutic systems or component thereof.
EP0875251A4 (en) Therapeutic agent and method for feline aids virus infections and feline atopic dermatitis
GB9929189D0 (en) Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
AU3336900A (en) Air treatment apparatus and system
AU3524700A (en) Prevention and treatment of viral infections
GB2357358B (en) System and method of group definition
HK1026598A (en) Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes